DE60216788D1 - Den calciumeinstrom hemmender faktor und verfahren zu dessen isolierung - Google Patents

Den calciumeinstrom hemmender faktor und verfahren zu dessen isolierung

Info

Publication number
DE60216788D1
DE60216788D1 DE60216788T DE60216788T DE60216788D1 DE 60216788 D1 DE60216788 D1 DE 60216788D1 DE 60216788 T DE60216788 T DE 60216788T DE 60216788 T DE60216788 T DE 60216788T DE 60216788 D1 DE60216788 D1 DE 60216788D1
Authority
DE
Germany
Prior art keywords
insulation
inhibiting factor
factor
calcium inhibitor
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60216788T
Other languages
English (en)
Other versions
DE60216788T2 (de
Inventor
Stephen Buescher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Eastern Virginia Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Medical School filed Critical Eastern Virginia Medical School
Application granted granted Critical
Publication of DE60216788D1 publication Critical patent/DE60216788D1/de
Publication of DE60216788T2 publication Critical patent/DE60216788T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60216788T 2001-09-12 2002-09-11 Den calciumeinstrom hemmender faktor und verfahren zu dessen isolierung Expired - Lifetime DE60216788T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32205701P 2001-09-12 2001-09-12
US322057P 2001-09-12
PCT/US2002/028814 WO2003022870A1 (en) 2001-09-12 2002-09-11 Calcium-influx inhibitory factor and method of isolation thereof

Publications (2)

Publication Number Publication Date
DE60216788D1 true DE60216788D1 (de) 2007-01-25
DE60216788T2 DE60216788T2 (de) 2007-10-04

Family

ID=23253222

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216788T Expired - Lifetime DE60216788T2 (de) 2001-09-12 2002-09-11 Den calciumeinstrom hemmender faktor und verfahren zu dessen isolierung

Country Status (10)

Country Link
US (3) US20050054566A1 (de)
EP (1) EP1434790B1 (de)
JP (1) JP4537704B2 (de)
AT (1) ATE348105T1 (de)
CA (1) CA2472102A1 (de)
DE (1) DE60216788T2 (de)
DK (1) DK1434790T3 (de)
ES (1) ES2278943T3 (de)
MX (1) MXPA04002387A (de)
WO (1) WO2003022870A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2366689C2 (ru) * 2003-12-12 2009-09-10 Коултэк Корпорейшн Методология сухого обогащения перед сжиганием и системы для улучшения характеристик твердого топлива

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229043D1 (de) * 1991-05-16 1999-06-02 Akzo Nobel Nv Das durch den monoklonalen menschlichen antikörper 81av78 erkannte antigen ctaa 81av78
WO1994009651A1 (en) * 1992-10-30 1994-05-11 Cancer Research Fund Of Contra Costa Anti-diarrheic product and method of treating rotavirus-associated infection
AUPM534794A0 (en) * 1994-04-28 1994-05-19 Gropep Pty Ltd Modified milk growth factor
JP4051475B2 (ja) * 1996-03-15 2008-02-27 バイオイコール アーゲー 成長因子複合体の抽出方法

Also Published As

Publication number Publication date
WO2003022870A1 (en) 2003-03-20
JP2005509601A (ja) 2005-04-14
US20050054566A1 (en) 2005-03-10
EP1434790A4 (de) 2004-11-24
US20110045590A1 (en) 2011-02-24
DE60216788T2 (de) 2007-10-04
EP1434790A1 (de) 2004-07-07
ES2278943T3 (es) 2007-08-16
US20090011998A1 (en) 2009-01-08
EP1434790B1 (de) 2006-12-13
ATE348105T1 (de) 2007-01-15
DK1434790T3 (da) 2007-04-10
JP4537704B2 (ja) 2010-09-08
CA2472102A1 (en) 2003-03-20
MXPA04002387A (es) 2004-11-22

Similar Documents

Publication Publication Date Title
AU2003278573A8 (en) Method and system for purification and disinfection of water
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69629238D1 (de) Vorrichtung zur Behandlung des Atemstillstands im Schlaf durch Elektrostimulation
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
ATE224189T1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
ATE369338T1 (de) Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE60043207D1 (de) Verfahren und Vorrichtung zur Reinigung von Gasen
HUP0402547A3 (en) Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
ATE522218T1 (de) Dosierungseinheit enthaltend prostaglandin-analog zur behandlung von darmverstopfung
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE19581626T1 (de) Verfahren und Vorrichtung zur Ioslierung und Reinigung von biologisch aktiven Komplexen
ATE290393T1 (de) Milchsäurebakterien zur behandlung und prophylaxe von giardiasis
HUP0202345A3 (en) Method of purifying water, suitable bacteria for the method and use thereof
ATE299371T1 (de) Antikonvulsiva zur behandlung von autismus
DE50010234D1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DE60216788D1 (de) Den calciumeinstrom hemmender faktor und verfahren zu dessen isolierung
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
FR2796071B1 (fr) Procede de purification de facteur de stimulation de colonies de granulocytes
ATE257143T1 (de) 15-hydroxyeicosatetraensäure verwandte verbindungen und anwendungsverfahren
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition